Strategic Acquisition ICORE Healthcare is part of a larger healthcare conglomerate, having been acquired by Cardinal Health, which indicates potential opportunities for partnership or integration within Cardinal's extensive distribution and supply chain networks.
Specialty Focus The company specializes in managing specialty pharmaceuticals, presenting opportunities to offer tailored solutions or expand product offerings to payors and healthcare providers focusing on high-cost drug segments.
Revenue Potential With estimated revenues between $25 million and $50 million and a dedicated team of up to 200 employees, ICORE Healthcare demonstrates growth potential and room for sales expansion through targeted engagements.
Technology Adoption ICORE leverages extensive data and resources to support decision-making in pharmaceutical management, suggesting a receptive environment for innovative tech solutions such as analytics, data integration, or digital platforms.
Market Positioning Operating within a competitive landscape alongside firms like CVS Caremark and Prime Therapeutics, ICORE Healthcare’s focus on specialty pharmacy management can be leveraged to introduce complementary products or services that address evolving market needs.
| ICORE Healthcare Email Formats | Percentage |
| FLast@icorehealthcare.com | 83% |
| First.Last@icorehealthcare.com | 8% |
| Last@icorehealthcare.com | 5% |
| FMiddleLast@icorehealthcare.com | 4% |
Pharmaceutical ManufacturingUnited States51-200 Employees
ICORE Healthcare is redefining how health care payors manage specialty pharmaceuticals.A specialist in a field of generalists, we use our vast knowledge, resources and data to help customers make smart decisions at a time when specialty pharmacy spending is at an all-time high.
Company Overview
Funding & FinancialsICORE Healthcare's revenue is estimated to be in the range of $25M$50M
Funding & FinancialsICORE Healthcare's revenue is estimated to be in the range of $25M$50M
1-888-653-2347 
support@leadiq.com